SR
Swayampakula Ramakanth HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
156
Avg Return
Past Year
Past Year
7.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Maintained
| $30 |
161%
upside
| 2 | +2.3% |
0
%
| 20 Oct ‘25 yesterday |
|
|
Buy
Reiterated
| $145 |
87%
upside
| 2 | +8.2% |
0
%
| 20 Oct ‘25 yesterday |
|
|
Buy
Reiterated
| $16 |
139%
upside
| 2 | +15% |
0
%
| 20 Oct ‘25 yesterday |
|
|
Buy
Reiterated
| $20 |
177%
upside
| 2 | +0.34% |
0
%
| 23 Sep ‘25 28 days ago |
|
|
Neutral
Downgraded
| – | – | 1 | +2% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
Buy
Reiterated
| $40 |
12%
upside
| 1 | +8.3% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Reiterated
| $8.50 |
15%
downside
| 2 | +15% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Buy
Reiterated
| $11 |
362%
upside
| 1 | -16% |
0
%
| 21 Aug ‘25 2 months ago |
|
|
Buy
Reiterated
| $8.50 |
108%
upside
| 3 | +31% |
0
%
| 19 Aug ‘25 2 months ago |
|
|
Buy
Reiterated
| $5 |
44%
upside
| 1 | +21% |
0
%
| 19 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $66 |
8%
downside
| 2 | +64% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
Neutral
Reiterated
| $1.50 |
72%
downside
| 1 | – |
–
| 14 Aug ‘25 2 months ago |
|
|
Buy
Reiterated
| $60 |
114%
upside
| 1 | -2.9% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $3.50 |
13%
upside
| 1 | -2.4% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $3 |
71%
upside
| 1 | +0.58% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $80 |
13%
upside
| 1 | +27% |
0
%
| 7 Aug ‘25 2 months ago |
|